253 related articles for article (PubMed ID: 37814551)
1. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
J Peripher Nerv Syst; 2023 Dec; 28(4):535-563. PubMed ID: 37814551
[TBL] [Abstract][Full Text] [Related]
2. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
Eur J Neurol; 2023 Dec; 30(12):3646-3674. PubMed ID: 37814552
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
van Doorn PA
Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
[TBL] [Abstract][Full Text] [Related]
4. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
Van den Bergh PYK; van Doorn PA; Hadden RDM; Avau B; Vankrunkelsven P; Allen JA; Attarian S; Blomkwist-Markens PH; Cornblath DR; Eftimov F; Goedee HS; Harbo T; Kuwabara S; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Sommer C; Topaloglu HA
J Peripher Nerv Syst; 2021 Sep; 26(3):242-268. PubMed ID: 34085743
[TBL] [Abstract][Full Text] [Related]
5. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
Van den Bergh PYK; van Doorn PA; Hadden RDM; Avau B; Vankrunkelsven P; Allen JA; Attarian S; Blomkwist-Markens PH; Cornblath DR; Eftimov F; Goedee HS; Harbo T; Kuwabara S; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Sommer C; Topaloglu HA
Eur J Neurol; 2021 Nov; 28(11):3556-3583. PubMed ID: 34327760
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
[TBL] [Abstract][Full Text] [Related]
7. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
Puma A; Benoit J; Sacconi S; Uncini A
BMC Neurol; 2018 Jul; 18(1):101. PubMed ID: 30031375
[TBL] [Abstract][Full Text] [Related]
8. [The prognosis and prognostic factor of Guillain-Barré Syndrome].
Yamagishi Y; Kusunoki S
Rinsho Shinkeigaku; 2020 Apr; 60(4):247-252. PubMed ID: 32238748
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
10. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Hughes RA; Wijdicks EF; Barohn R; Benson E; Cornblath DR; Hahn AF; Meythaler JM; Miller RG; Sladky JT; Stevens JC;
Neurology; 2003 Sep; 61(6):736-40. PubMed ID: 14504313
[TBL] [Abstract][Full Text] [Related]
11. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
[TBL] [Abstract][Full Text] [Related]
12. The utility of Guillain-Barré syndrome prognostic models in Malaysian patients.
Tan CY; Razali SNO; Goh KJ; Shahrizaila N
J Peripher Nerv Syst; 2019 Jun; 24(2):168-173. PubMed ID: 31001904
[TBL] [Abstract][Full Text] [Related]
13. IVIG treatment and prognosis in Guillain-Barré syndrome.
van Doorn PA; Kuitwaard K; Walgaard C; van Koningsveld R; Ruts L; Jacobs BC
J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S74-8. PubMed ID: 20396937
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome: clinical profile and management.
Sudulagunta SR; Sodalagunta MB; Sepehrar M; Khorram H; Bangalore Raja SK; Kothandapani S; Noroozpour Z; Aheta Sham M; Prasad N; Sunny SP; Mohammed MD; Gangadharappa R; Nidsale Sudarshan R
Ger Med Sci; 2015; 13():Doc16. PubMed ID: 26421004
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.
El-Bayoumi MA; El-Refaey AM; Abdelkader AM; El-Assmy MM; Alwakeel AA; El-Tahan HM
Crit Care; 2011 Jul; 15(4):R164. PubMed ID: 21745374
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for Neuroprognostication in Adults with Guillain-Barré Syndrome.
Busl KM; Fried H; Muehlschlegel S; Wartenberg KE; Rajajee V; Alexander SA; Creutzfeldt CJ; Fontaine GV; Hocker SE; Hwang DY; Kim KS; Madzar D; Mahanes D; Mainali S; Meixensberger J; Sakowitz OW; Varelas PN; Westermaier T; Weimar C
Neurocrit Care; 2023 Jun; 38(3):564-583. PubMed ID: 36964442
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2012 Jul; (7):CD002063. PubMed ID: 22786476
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in Guillain-Barré syndrome].
Kaida K
Rinsho Shinkeigaku; 2013; 53(11):1315-8. PubMed ID: 24291972
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of chief complaints to predict severity, ventilator dependence, treatment option, and short-term outcome of patients with Guillain-Barré syndrome: a retrospective study.
Wang Y; Shang P; Xin M; Bai J; Zhou C; Zhang HL
BMC Neurol; 2017 Nov; 17(1):200. PubMed ID: 29157205
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence- and consensus-based guideline.
Korinthenberg R; Trollmann R; Felderhoff-Müser U; Bernert G; Hackenberg A; Hufnagel M; Pohl M; Hahn G; Mentzel HJ; Sommer C; Lambeck J; Mecher F; Hessenauer M; Winterholler C; Kempf U; Jacobs BC; Rostasy K; Müller-Felber W
Eur J Paediatr Neurol; 2020 Mar; 25():5-16. PubMed ID: 31941581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
